Micro-targeted Computerized Alcohol Misuse Intervention System for Health Care

用于医疗保健的微目标计算机酒精滥用干预系统

基本信息

  • 批准号:
    8715016
  • 负责人:
  • 金额:
    $ 51.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2016-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alcohol misuse continues to pose a major burden for public health. Screening and brief intervention for alcohol misuse in primary care settings has been recommended for decades, and the evidence base supporting it in primary care is robust. However, many primary care providers do not intervene in alcohol misuse, and those that do often fail to do so systematically or in accordance with best-evidence standards. Computerization of screening and brief intervention for alcohol misuse holds the promise of alleviating many of the barriers that have prevented its adoption into routine care, and also offers new opportunities for optimizing the effectiveness of brief interventions. This Phase 2 STTR project follows up on Research Circle Associates' successful proof- of-concept work done under Phase 1, which led to the development of a versatile software platform (Interventionaire(c)) to support computerized alcohol misuse screening and brief intervention using evidence- based strategies including motivational interviewing and normative feedback. Our computerized alcohol misuse intervention includes a normative feedback component that is unique in its micro-targeting of alcohol use feedback based on participant demographic characteristics (race/ethnicity, gender, and age), drawing population normative data from the National Surveys on Drug Use and Health. This represents a novel use of epidemiological data to inform clinical services. The Phase 2 project is designed to answer a number of important research questions and prepare the product for successful commercialization. Specifically, during Phase 2 we intend to implement several refinements into the (Interventionaire(c)) platform that will increase its usability and streamline the creation of complex content with tailored feedback. We will also upgrade the software to make it compatible with a major electronic health record system used by our clinical partner site. This will increase the reach of the product and ensure maximum readiness for deployment into the modern healthcare marketplace, a dynamic and rapidly evolving industry. We will also conduct a study at our clinical partner site using qualitative key informant, focus group, and survey methodologies to investigate barriers to adopting computerized alcohol screening and brief intervention systems. A critical question is whether the computerized alcohol misuse intervention is effective in changing drinking behavior. To answer this question, we will conduct a cross-over randomized controlled trial examining the short-term impact of the computerized alcohol misuse intervention with micro-targeted normative feedback and motivational messaging compared to an "attention-control" (placebo) generic health promotion message. This trial will help to establish the short- term efficacy of the intervention and set the stage for larger trials and adoption of the product i healthcare settings. Finally, we will conduct a projection analysis of the economic and health impacts of the intervention under a variety of assumptions regarding intervention effect size, target population, and product penetration. Satisfying these Phase 2 objectives will leave RCA well-poised to deploy the product commercially, which will leverage the power of the market to improve clinical service delivery and promote public health.
描述(由申请人提供):滥用酒精会继续为公共卫生带来重大负担。数十年来,建议在初级保健环境中进行筛查和简短的滥用酒精滥用,并且在初级保健中支持它的证据基础是强大的。但是,许多初级保健提供者不会干预滥用酒精,而那些通常无法系统地或符合最佳证据标准的提供者。筛查的计算机化和对酒精滥用的简短干预措施有望减轻许多阻止其采用常规护理的障碍,并为优化短暂干预的有效性提供了新的机会。该第2阶段的STTR项目跟进了研究圈中的协会协会的成功证明,在第1阶段完成的工作,这导致了多功能软件平台(Issentionaire(c))的开发,以支持计算机化的酒精滥用筛查和使用短暂的干预基于证据的策略,包括动机访谈和规范反馈。我们的计算机化酒精滥用干预包括基于参与者人口特征(种族/民族,性​​别和年龄)的酒精使用反馈的规范反馈组成部分,从全国性使用毒品使用和培训人口规范性数据。健康。这代表了流行病学数据的新颖使用来为临床服务提供信息。第二阶段项目旨在回答许多重要的研究问题,并为成功的商业化准备产品。具体而言,在第2阶段,我们打算将多个改进实施到(Ispentionaire(C))平台中,以提高其可用性并简化使用量身定制的反馈来创建复杂内容。我们还将升级该软件,使其与临床合作伙伴网站使用的主要电子健康记录系统兼容。这将增加产品的覆盖范围,并确保最大的部署到现代医疗保健市场,这是一个动态且迅速发展的行业。我们还将使用定性的关键线人,焦点小组和调查方法在我们的临床合作伙伴站点进行一项研究,以调查采用计算机化酒精筛查和简短干预系统的障碍。一个关键的问题是计算机化的酒精滥用干预措施是否有效改变饮酒行为。为了回答这个问题,我们将进行一项跨界随机对照试验,以检查计算机化酒精滥用干预措施的短期影响,并与“注意力控制”(安慰剂)(安慰剂)促进相比,以微目标的规范反馈和动机消息传递信息。该试验将有助于建立干预措施的短期疗效,并为更大的试验和采用I Healthcare设置奠定了基础。最后,我们将在各种假设下对干预效果规模,目标人群和产品渗透的各种假设下的经济和健康影响进行投影分析。满足这些阶段2的目标将使RCA畅通无阻,以商业部署产品,这将利用市场的力量来改善临床服务的交付并促进公共卫生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Diana Howard Caldwell其他文献

Diana Howard Caldwell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Diana Howard Caldwell', 18)}}的其他基金

Performance Improvement Technology in Urban Native American Health Organizations
城市美洲原住民卫生组织的绩效改进技术
  • 批准号:
    8472251
  • 财政年份:
    2013
  • 资助金额:
    $ 51.09万
  • 项目类别:
Performance Improvement Technology in Urban Native American Health Organizations
城市美洲原住民卫生组织的绩效改进技术
  • 批准号:
    8739670
  • 财政年份:
    2013
  • 资助金额:
    $ 51.09万
  • 项目类别:
Computerized Alcohol Misuse Intervention with Micro-targeted Normative Feedback
具有微目标规范反馈的计算机化酒精滥用干预
  • 批准号:
    8251332
  • 财政年份:
    2011
  • 资助金额:
    $ 51.09万
  • 项目类别:
Innovative Computer Prototype for HIV Screening and Brief Intervention
用于艾滋病毒筛查和短暂干预的创新计算机原型
  • 批准号:
    7928526
  • 财政年份:
    2010
  • 资助金额:
    $ 51.09万
  • 项目类别:
Preventing Substance Abuse, HIV/AIDS, and Hepatitis in Native Americans
预防美洲原住民的药物滥用、艾滋病毒/艾滋病和肝炎
  • 批准号:
    7658306
  • 财政年份:
    2005
  • 资助金额:
    $ 51.09万
  • 项目类别:
Preventing Substance Abuse, HIV/AIDS, and Hepatitis in Native Americans
预防美洲原住民的药物滥用、艾滋病毒/艾滋病和肝炎
  • 批准号:
    7448629
  • 财政年份:
    2005
  • 资助金额:
    $ 51.09万
  • 项目类别:

相似国自然基金

锶银离子缓释钛表面通过线粒体自噬调控NLRP3炎症小体活化水平促进骨整合的机制研究
  • 批准号:
    82301139
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
万寿菊黄酮通过MAPK/Nrf2-ARE通路缓解肉鸡肠道氧化应激损伤的作用机制
  • 批准号:
    32302787
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肠道菌群及其代谢产物通过mRNA m6A修饰调控猪肉品质的机制研究
  • 批准号:
    32330098
  • 批准年份:
    2023
  • 资助金额:
    220 万元
  • 项目类别:
    重点项目
PUFAs通过SREBPs提高凡纳滨对虾低盐适应能力的机制研究
  • 批准号:
    32303021
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
EGLN3羟化酶通过调控巨噬细胞重编程促进肺癌细胞EMT及转移的机制研究
  • 批准号:
    82373030
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Sustainability determinants of an intervention to identify clinical deterioration and improve childhood cancer survival in low-resource hospitals
在资源匮乏的医院中识别临床恶化并提高儿童癌症生存率的干预措施的可持续性决定因素
  • 批准号:
    10562780
  • 财政年份:
    2023
  • 资助金额:
    $ 51.09万
  • 项目类别:
The RaDIANT Health Systems Intervention for Equity in Kidney Transplantation
Radiant 卫生系统干预肾移植的公平性
  • 批准号:
    10681998
  • 财政年份:
    2023
  • 资助金额:
    $ 51.09万
  • 项目类别:
Testing and Texting in Community Health Center Dental Clinics to Diagnose and Prevent HIV Infection
在社区健康中心牙科诊所进行检测和发短信以诊断和预防艾滋病毒感染
  • 批准号:
    10864322
  • 财政年份:
    2023
  • 资助金额:
    $ 51.09万
  • 项目类别:
Implementation of PrEP Care Among Women in Family Planning Clinics
在计划生育诊所对妇女实施 PrEP 护理
  • 批准号:
    10744477
  • 财政年份:
    2023
  • 资助金额:
    $ 51.09万
  • 项目类别:
UTEP FIRST Admin Core
UTEP FIRST 管理核心
  • 批准号:
    10664695
  • 财政年份:
    2023
  • 资助金额:
    $ 51.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了